Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | Case report

Ipilimumab/nivolumab

Multisystem toxicities: 20 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Iravani A, et al. FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment. European Journal of Nuclear Medicine and Molecular Imaging 47: 2776-2786, No. 12, Nov 2020. Available from: URL: http://doi.org/10.1007/s00259-020-04815-w Iravani A, et al. FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment. European Journal of Nuclear Medicine and Molecular Imaging 47: 2776-2786, No. 12, Nov 2020. Available from: URL: http://​doi.​org/​10.​1007/​s00259-020-04815-w
Metadaten
Titel
Ipilimumab/nivolumab
Multisystem toxicities: 20 case reports
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-88257-9

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Antineoplastics